Organ Preservation Market Size
The Global Organ Preservation Market reached US$ 292.20 million in 2025 and is expected to reach US$ 463.90 million by 2033, growing at a CAGR of 5.86% during the forecast period 2026-2033.
The organ transplantation involves an organ removal from a donor body, transporting the organ, and transplanting into another body, all while preserving the organ without significant damage. Creating hypothermia by reducing the organ temperature may help preservation, but different body organs need precise and appropriate storage environments to maintain their anatomical and physiological processes.
Organ Preservation Market Summary
| Metrics | Details |
| Market CAGR | 5.86% |
| Segments Covered | By Technique, By Preservation Solution, By Organ Type, By End-user, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
To Know More Download Sample
Organ Preservation Market Trends
The major driving forces are the rising incidence of organ failures, increase in research and development, technological advancements and rising chronic kidney disease are expected to drive market growth.
The rising incidences of multiple organ failures is expected to drive the market growth
The global market for organ preservation market is primarily driven by the rising cases of multiple organ failure. The increasing number of solid-organ transplantation procedures coupled with an aging population are expected to promote market growth.
Increase in cases of chronic kidney diseases leads to increase in kidney transplants worldwide. Earlier a recipient can receive kidney only from the same blood group which led to delay in finding a proper donor. Delay in transplant was responsible for increased mortality. Kidney transplant is the most desired and cost-effective modality of renal replacement therapy for patients with irreversible chronic kidney failure. According to National Institute of Health (NIH), chronic kidney disease, has a high global prevalence with a consistent estimated global prevalence of between 11 to 13% with the majority stage 3.
Other factors such as the growing government and NGO initiatives to encourage organ donation along with the increasing awareness of organ donations assist the market development. Technological advancements, for example, the normothermic machine perfusion which is a new paradigm for organ preservation also contribute to market growth.
The high cost associated with the organ transplantation will hamper the growth of the market
However, the high cost of organ transplantation, a significant gap between the number of organs donated and organs required annually, and limited medical reimbursements for organ donation and transplantation may hinder the market progress.
Organ Preservation Market Segmentation Analysis
The static cold storage segment is expected to grow at the fastest CAGR during the forecast period (2026-2033).
The static cold storage (SCS) segment is the highest market share holder in the global organ preservation market, owing to the increased number of incidences od organ failutes leading to growing organ transplantation and research activities. Transition of secured organs of donor on ice is involved in static cold storage. It has been the best standard for the preservation of multiple orgns for many decades. Static cold storage depends on hypothermia by which it minimizes the demand of oxygen as well as cellular metabolism and get to extend the time of preservation of organs. During cold storage, organ’s metabolic activity gets reduced around 10 times and increases anaerobic metabolism that stops the energy cycle. According to nature journal publication titled “Organ preservation: from past to future”, The static cold storage is the most effective and simple way for preservation and transportation of the organs. This is the most common method used for the preservation of organs.
Global Organ Preservation Market Geographical Share
North America region holds the largest market share of the global organ preservation market
North America dominates the global organ preservation market, and it is primarily attributed to the rising geriatric population leading to the higher occurrence of organ failures. The growing prevalence of cardiovascular diseases and the increasing cases of kidney failure are likely to enhance the growth of organ preservation. Furthermore, factors such as high spending of GDP in healthcare, growing government initiatives, and reimbursement policies in advanced medical treatment options are likely to enhance the growth of the organ preservation market in the region.
Recent Developments
March 2026: TransMedics Group, Inc. and XVIVO Perfusion AB continued advancements in machine perfusion technologies, enabling real-time monitoring and extended preservation of organs, significantly improving transplant success rates and utilization.
February 2026: OrganOx Limited and Paragonix Technologies, Inc. strengthened development of portable and normothermic perfusion systems, supporting longer preservation times and better organ viability during transportation.
January 2026: BioLife Solutions, Inc. expanded its biopreservation media and cold chain solutions portfolio, enhancing storage stability and reducing ischemic injury in transplant organs.
December 2025: Science Corporation introduced next-generation automated perfusion systems designed to extend organ preservation duration and reduce system complexity, aiming to improve accessibility and cost-efficiency in transplantation.
November 2025: Medtronic plc and other industry players increased investments in advanced preservation technologies and transplant infrastructure, supporting the shift from static cold storage to dynamic preservation systems.
October 2025: Institut Georges Lopez (IGL) and Bridge to Life Ltd. enhanced preservation solutions, such as UW and Custodiol HTK, to address growing demand driven by rising cases of organ failureand transplant procedures globally.
The market is rapidly evolving toward advanced machine perfusion and integrated preservation systems, in which real-time monitoring, improved storage solutions, and rising transplant demand are enhancing organ viability, reducing discard rates, and improving overall transplant outcomes worldwide.
Organ Preservation Market Companies and Competitive Landscape
The organ preservation market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market are Xvivo Perfusion AB, CryoLife, Inc., Lifeline Scientific, BioTime, Inc., Claris Lifesciences Limited, BioLife Solutions, Inc., Dr. Franz Kohler Chemie GmbH, Bristol-Myers Squibb, Tolerotech, Inc. and 21st Century Medicine.
Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches along with an increased focus on R&D are other ways the leading players improve their market presence. For instance, in Oct 2021, Xvivo, medical technology company announced its acquisition of STAR teams, a specialized AI-adapted transplant recovery. They work on combined data-driven approach.
In Aug 2021, BioLife Solution, developer and provider of cell therapies or gene therapies products and therapies announced its acquisition of Sexton Biotechnologies Inc.
XVIVO Perfusion AB:
Overview:
Xvivo is a company of medical technology that develops better solutions for organ, cell and tissue preservation or perfusion that can be used for transplantation. It was established in 1998 and is headquartered in Gothenburg, Sweden. It operates in three different segments: durable goods, non-durable goods and services.
Product Portfolio:
PERFADEX Plus: It is a dextran-based electrolyte, extracellular with low potassium preservation solution for perfusion, rapid cooling and cold static storage of lungs of donor. It is already supplemented with THAM and calcium ions hence easy and ready to use.
The global organ preservation market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.
